Two Sigma Investments, LP Eton Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.06 - $3.75 $46,833 - $57,393	-15,305 Reduced 48.14%	16,485 $54,000
Q1 2024 May 15, 2024	SELL	$3.48 - $5.03 $72,070 - $104,171	-20,710 Reduced 39.45%	31,790 $119,000
Q4 2023 Feb 14, 2024	SELL	$3.45 - $4.66 $93,329 - $126,062	-27,052 Reduced 34.01%	52,500 $229,000
Q3 2023 Nov 14, 2023	BUY	$2.55 - $5.63 $202,857 - $447,877	79,552 New	79,552 $331,000
Q4 2021 Feb 14, 2022	SELL	$3.66 - $6.59 $66,136 - $119,081	-18,070 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.2 - $6.26 $75,894 - $113,118	18,070 New	18,070 $91,000
Q2 2021 Aug 16, 2021	SELL	$5.71 - $8.85 $799,337 - $1.24 Million	-139,989 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.93 - $10.07 $93,548 - $135,934	13,499 Added 10.67%	139,989 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$6.65 - $8.83 $841,158 - $1.12 Million	126,490 New	126,490 $1.03 Million

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $318M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.